10-86654905-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_033282.4(OPN4):c.122G>A(p.Arg41Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000124 in 1,592,318 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_033282.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OPN4 | NM_033282.4 | c.122G>A | p.Arg41Gln | missense_variant | 1/10 | ENST00000241891.10 | |
OPN4 | NM_001030015.3 | c.122G>A | p.Arg41Gln | missense_variant | 1/11 | ||
OPN4 | XM_017016955.2 | c.122G>A | p.Arg41Gln | missense_variant | 1/10 | ||
OPN4 | XM_017016956.2 | c.122G>A | p.Arg41Gln | missense_variant | 1/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OPN4 | ENST00000241891.10 | c.122G>A | p.Arg41Gln | missense_variant | 1/10 | 1 | NM_033282.4 | P1 | |
OPN4 | ENST00000372071.7 | c.122G>A | p.Arg41Gln | missense_variant | 1/11 | 1 | |||
OPN4 | ENST00000690949.1 | n.145+243G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000463 AC: 7AN: 151224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250968Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135738
GnomAD4 exome AF: 0.000133 AC: 191AN: 1441094Hom.: 0 Cov.: 36 AF XY: 0.000135 AC XY: 97AN XY: 716682
GnomAD4 genome AF: 0.0000463 AC: 7AN: 151224Hom.: 0 Cov.: 33 AF XY: 0.0000271 AC XY: 2AN XY: 73866
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 19, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at